Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC   ADCOCK INGRAM
EQUITY SHARE DATA
    ALEMBIC
Mar-23
ADCOCK INGRAM
Jun-14
ALEMBIC/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs87319-   
Low Rs56230-   
Sales per share (Unadj.) Rs5.094.9-  
Earnings per share (Unadj.) Rs3.1-23.9-  
Cash flow per share (Unadj.) Rs3.4-19.8-  
Dividends per share (Unadj.) Rs2.200-  
Avg Dividend yield %3.10-  
Book value per share (Unadj.) Rs80.974.5-  
Shares outstanding (eoy) m256.78168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x14.42.9 497.0%   
Avg P/E ratio x22.7-11.5 -197.7%  
P/CF ratio (eoy) x21.0-13.9 -151.2%  
Price / Book Value ratio x0.93.7 23.9%  
Dividend payout %70.10-   
Avg Mkt Cap Rs m18,29846,340 39.5%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m2402,908 8.3%   
Avg. sales/employee Rs Th03,730.7-  
Avg. wages/employee Rs Th0677.5-  
Avg. net profit/employee Rs Th0-940.1-  
INCOME DATA
Net Sales Rs m1,27216,016 7.9%  
Other income Rs m643112 573.0%   
Total revenues Rs m1,91516,128 11.9%   
Gross profit Rs m297-2,775 -10.7%  
Depreciation Rs m67691 9.7%   
Interest Rs m5434 1.1%   
Profit before tax Rs m868-3,788 -22.9%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62237 26.1%   
Profit after tax Rs m806-4,036 -20.0%  
Gross profit margin %23.4-17.3 -134.8%  
Effective tax rate %7.1-6.2 -113.9%   
Net profit margin %63.4-25.2 -251.4%  
BALANCE SHEET DATA
Current assets Rs m1,72111,730 14.7%   
Current liabilities Rs m8386,600 12.7%   
Net working cap to sales %69.432.0 216.7%  
Current ratio x2.11.8 115.6%  
Inventory Days Days5,038111 4,543.0%  
Debtors Days Days673124 542.8%  
Net fixed assets Rs m20,3246,838 297.2%   
Share capital Rs m51474 690.6%   
"Free" reserves Rs m20,2670-   
Net worth Rs m20,78012,571 165.3%   
Long term debt Rs m04,418 0.0%   
Total assets Rs m22,04623,747 92.8%  
Interest coverage x187.7-7.7 -2,427.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.10.7 8.6%   
Return on assets %3.7-15.2 -24.2%  
Return on equity %3.9-32.1 -12.1%  
Return on capital %4.2-19.8 -21.2%  
Exports to sales %1.20-   
Imports to sales %2.40-   
Net fx Rs m-140-   
CASH FLOW
From Operations Rs m3891,367 28.4%  
From Investments Rs m73-420 -17.4%  
From Financial Activity Rs m-4644,009 -11.6%  
Net Cashflow Rs m-24,957 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.4 Rs / ZAR

Compare ALEMBIC With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC With: FDC  BETA DRUGS   WALPAR NUTRITIONS LTD.  GUFIC BIOSCIENCE  J.B.CHEMICALS  



Today's Market

Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today(Pre-Open)

Indian share markets Slipped further as the session progressed and ended the day weak.